Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
S&P Biotech Bull 3X ETF Direxion
(NY:
LABU
)
121.04
-3.96 (-3.17%)
Streaming Delayed Price
Updated: 11:50 AM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about S&P Biotech Bull 3X ETF Direxion
Can These 5 Assets Skyrocket Your Portfolio?
September 22, 2024
Are Verizon, Amazon, Cisco, Amgen, and the S&P Biotech Bull 3X Shares ETF poised to make your portfolio skyrocket? In this video, I take a closer look.
Via
Talk Markets
Topics
ETFs
Stocks
Exposures
US Equities
EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks
August 30, 2024
Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment.
Via
Benzinga
Tech Powers S&P 500, Nasdaq, Leveraged ETFs Win
June 06, 2024
Wall Street piled up strong gains in yesterday’s trading session, with the S&P 500 hitting the 25th record high this year and the Nasdaq Composite Index touching another record.
Via
Talk Markets
Topics
ETFs
Stocks
Exposures
US Equities
The 3 Best Leveraged ETFs for April 2024
April 02, 2024
If you want to speculate on baskets of securities, then these best leveraged ETFs for April could be what the doctor ordered.
Via
InvestorPlace
Topics
ETFs
Sector Rotation
January 08, 2022
In this video, I discuss sector rotation out of technology stocks and into consumer staple, energy, and bank stocks.
Via
Talk Markets
5 Best-Performing Leveraged ETFs Of February
March 02, 2024
U.S. stocks rallied in February, with the S&P 500 and the Nasdaq Composite Index recording the best month in nearly a decade. Amid this environment, here are some of the best-performing leveraged...
Via
Talk Markets
Topics
ETFs
Stocks
Exposures
US Equities
Stocks To Watch This Week - Sunday, Feb. 11
February 11, 2024
This week, we take a look at small-cap and mid-cap stocks by using ETFs such as MDY and the leveraged ETF TNA. We also like the look of the LABU ETF.
Via
Talk Markets
Topics
ETFs
Want Diversified Upside in Biotechnology? Check out LABU
March 22, 2023
Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility.
Via
MarketBeat
Topics
ETFs
Stocks
Exposures
US Equities
The Week Ahead Commentary - Saturday, Feb. 4
February 05, 2023
Robert Desmond looks at ETF and individual equities for the week just ended and gives his take on trading for the week to come.
Via
Talk Markets
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
January 17, 2023
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.
Via
Talk Markets
3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty
February 22, 2022
Here are 3 stocks to buy on dips from scary geopolitical risks from Russia. These leveraged ETFs move extremely fast so bring your Dramamine.
Via
InvestorPlace
The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)…
February 11, 2022
China Tech (Alibaba) and Biotech have been the two least-loved sectors in recent weeks, but we believe this is changing.
Via
Talk Markets
3 Biotech Stocks to Buy That Are Under Severe Pressure
January 13, 2022
The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.
Via
InvestorPlace
5 Best Leveraged ETFs of Last Week
December 28, 2021
The S&P 500 hit a record close last week, courtesy of a Santa Clause rally. Wall Street was charged-up with the S&P 500 (up 1.22%), the Dow Jones (up 0.15%), the Nasdaq Composite (up 3.12%) and the...
Via
Talk Markets
5 Best-Performing Leveraged ETFs of August
September 01, 2021
Here are some best-performing leveraged equity ETFs from different corners of the market that gained in double digits in August.
Via
Talk Markets
The Week In Charts: Figure This Out And You’ll Own The World
August 07, 2021
A discussion on trading hot IPOs and some of the issues that have arisen in recent times.
Via
Talk Markets
The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs
July 31, 2021
A look at lessons learned from active trading of IPOs, ETFs, Russian Dolls, and a discussion on what might be the secret to trading-which ironically, is the polar opposite to trading.
Via
Talk Markets
The Week In Charts: Trading Stuff Part 2-IPOs, ETFs, And, The Secret To Trading
July 23, 2021
A look at lessons learned from active trading including what might be the secret to trading-which ironically is the polar opposite to trading.
Via
Talk Markets
These Were The Stocks David Green Discussed On His Show This Morning
July 06, 2021
David Green made money day trading Bridgeline Digital Inc (NASDAQ:
Via
Benzinga
The Week In Charts-Volatility: Rabbit Hole Or Holy Grail?
June 11, 2021
A revisit using volatility to let us know when the elusive
Via
Talk Markets
A Biotech ETF For Aggressive, Risk-Tolerant Investors
June 08, 2021
The Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) seeks the daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Index for a single day.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
A Biotech ETF For Aggressive, Risk-Tolerant Investors
June 08, 2021
The biotechnology sector has been on fire thanks to news from Biogen Inc. (NASDAQ: BIIB). The FDA approved its controverisal drug that can treat Alzheimer’s Disease. Not...
Via
Benzinga
Exposures
Product Safety
CrowdStrike Stock Earnings Trade
June 06, 2021
In this video, we review the CrowdStrike stock earnings trade. We also review our top five stocks for the new trading week.
Via
Talk Markets
This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming
May 05, 2021
Humanigen Inc. (NASDAQ: HGEN) shares made gains Wednesday following the publication of results from a Phase 3 randomized double-blind placebo-controlled study. The...
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.